您的位置:网站名称 研发专利新闻 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

USPTO issues Notice of Allowance to AlphaRx ARX8203 pain product candidate


AlphaRx Inc. (OTC BB:ALRX.OB) has received a Notice of Allowance from the United States Patent and Trademark Office for its lead pain product candidate code named ARX8203, a potentially safer drug intended for pain treatment. AlphaRx has...

查看所有的文章内容需要 VIP会员权限 查看


 
点这里复制本页地址发送给您QQ/MSN上的好友

相关文章

VARI, Gentel Biosciences receive U.S. Pa
Colorcon announces specific details on i
ACT to be awarded broad patent protectio
NephRx receives new U.S. patent for NX00
USPTO grants patent to ULURU's Altrazeal
NephRx receives new U.S. patent for NX00
PRWP receives two new patents for Galect
POZEN files motion for Treximet patent l
BDSI's BEMA drug delivery technology rec
USPTO grants patent to HistoRx methods f
US District Court rules against Watson i
U.S. District Court rules in favor of Wa
Biotectix acquires Chameleon BioSurfaces
USPTO issues Notice of Allowance to Modu
USPTO issues patent to Somaxon's Silenor
USPTO grants composition-of-matter paten
USPTO issues patent to Asterand's BioMAP
Medical industry veteran set to play key
Cubist enters license agreement with Tev
Shire files lawsuit against Watson over

相关评论


本文章所属分类:首页 研发专利新闻